Search

Your search keyword '"Payeras, Antoni"' showing total 197 results

Search Constraints

Start Over You searched for: Author "Payeras, Antoni" Remove constraint Author: "Payeras, Antoni"
197 results on '"Payeras, Antoni"'

Search Results

1. A genome-wide association study of adults with community-acquired pneumonia

2. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

3. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

5. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

7. Should MASP-2 Deficiency Be Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway

8. QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing : A Noninferiority Clinical Trial

10. Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression : Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

11. A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes

12. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

13. A genome-wide association study of adults with community-acquired pneumonia

15. Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial

19. Reinforcement of the Standard Therapy with Two Infusions of Convalescent Plasma for Patients with COVID-19: A Randomized Clinical Trial

22. DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks)

23. ELABORACIÓN DE UN MODELO DE TASA MUNICIPAL SOBRE LOS RESIDUOS COMERCIALES.

24. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

27. Dioxygen binding to complexes with Fe(super II)(sub 2)(mu-OH)(sub 2) cores: Steric control of activation barriers and O(sub 2)-adduct formation

29. Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old

30. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naïve Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

31. Efficient and selective aerobic oxidation of alcohols into aldehydes and ketones using ruthenium/TEMPO as the catalytic system

34. Challenges in understanding host genetics and severity of community-acquired pneumonia

39. Effects of escin on indinavir crystallization time in the urine of patients with HIV-I infection: A multicenter, randomized, open-label, controlled, four-period crossover trial

40. Should MASP-2 Deficiency Be Considered a Primary Immunodeficiency? Relevance of the Lectin Pathway

41. Polyserositis: a diagnostic challenge

42. Kinetic analysis of the conversion of nonheme (alkylperoxo)iron(III) species to iron(IV) complexes

43. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

44. Factors associated with the number of drugs in darunavir/cobicistat regimens.

45. Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial

Catalog

Books, media, physical & digital resources